The Russian Consumer Safety Agency announced, on Tuesday, that the country expects to register its second potential vaccine against Covid-19, which is caused by the Corona virus, in mid-October.
And the “TASS” news agency reported that Moscow expects to register a possible second vaccine to prevent Covid-19 by October 15th.
The head of the government fund, which is financing the Russian COVID-19 vaccine project, told Reuters that Russia is so confident in the success of its vaccine that it will bear some of the legal risks if things go wrong rather than requiring buyers to accept full responsibility.
“Russia is so confident of its vaccine that it has not requested a full guarantee, and this is a different factor than any Western vaccine,” said Kirill Dmitriev, head of the Russian Direct Investment Fund, the Russian sovereign wealth fund that supports the vaccine, adding that all Western companies have requested protection from any claims.
The vaccine was developed by the Victor Institute in Siberia, which completed early human trials last week.
Russia recorded its first candidate vaccine against the Coronavirus, which was developed by the Moscow Aesthetic Institute in August, and the last-phase trials, which include at least 40,000 people, are still underway.
On August 26, the Russian Direct Investment Fund announced that Russia had started a new phase of clinical trials of the “Sputnik-5” vaccine against the emerging corona virus.
The first Russian vaccine received praise as safe and effective from the authorities and Russian scientists, following two months of small-scale human trials, the results of which have not yet been announced.
Russia said that the vaccine, which was developed by the “Gamalia” Institute in Moscow and the Russian Ministry of Defense, and is the first to begin production to treat the Corona virus, and will be offered at the end of this August.
It is noteworthy that the Russian vaccine, Sputnik-5, has raised concerns among some experts. Several countries announced their doubts about the vaccine.
Germany questioned the quality, effectiveness and safety of the Russian vaccine.
France said it is waiting for major laboratories to obtain the vaccine and confirm its effectiveness.
The World Health Organization (WHO) had announced its reservation on it, noting that its information about the vaccine is not sufficient and therefore it is difficult to evaluate it.
